BPA Call 36E79726A0012-36C24526N0772
Award Date 7/28/26
Potential Completion Date 7/29/26
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Takeda Pharmaceuticals America, Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract for $43,471.17 to provide ICLUSIG (ponatinib) to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The order has a completion date of April 29, 2024 and was awarded on February 29, 2024 under a firm fixed price arrangement. Takeda Pharmaceuticals America currently holds an active blanket purchase agreement...
- Veterans Integrated Service Network 5 issued a BPA call to Takeda Pharmaceuticals America, Inc. for TAKHZYRO 150 mg with a ceiling value of $38,097.52 and an award date of July 24, 2026. The call is placed against a Blanket Purchase Agreement with the VA National Acquisition Center for ICLUSIG, a targeted cancer therapy for chronic myeloid leukemia and acute lymphoblastic leukemia. Place of performance is Brooks, Kentucky. The ultimate completion date is July 28, 2026. Takeda is a large,...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of ICLUSIG 15 MG, a specialty oncology medication, to VA medical facilities. The contract has a ceiling value of $14,197.39 and a completion date of October 8, 2025. Takeda Pharmaceuticals America, Inc. holds a $123.5 million Blanket Purchase Agreement (BPA) with the VA...
- The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call order to Takeda Pharmaceuticals America, Inc. to supply the oncology medication ICLUSIG (ponatinib) 15mg to VA medical facilities nationwide. This $39,130.29 firm-fixed-price contract was placed against Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has an ultimate completion date of August 2, 2024. The parent company of the prime contractor,...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $69,783.60 and supports the delivery of the oncology medication ICLUSIG (ponatinib) to VA medical facilities nationwide through September 2024. The contract is issued under Takeda's existing General Services Administration (GSA) Schedule 61-IB for...
- This federal contract award is for the delivery of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA). The prime contractor is Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $14,197.39 and is a firm-fixed-price delivery order under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. It supports the VA's Veterans Integrated Service...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, based in Japan. The contract is for the supply of ICLUSIG 15 MG, a specialty oncology medication used to treat certain types of leukemia. The contract has a firm-fixed-price pricing type and a ceiling value of $13,956.72, with an ultimate completion date of December 10, 2024....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $13,956.72 firm fixed price delivery order contract to Takeda Pharmaceuticals America, Inc. for ICLUSIG 15 MG. The contract was awarded on January 25, 2024 and is to be completed by January 30, 2024. It utilizes the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle, with performance taking place in Earth City, Missouri. Takeda Pharmaceuticals...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract is for the supply of ICLUSIG 45 MG, a specialty oncology medication, to various VA medical facilities across the country. The contract has a ceiling value of $13,956.72 and is a firm-fixed-price delivery order placed against Takeda's General Services Administration (GSA) Schedule...
- The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceutical Company LIMITED is the parent company of the prime contractor. The contract was awarded against Takeda's Pharmaceuticals and Drugs GSA Schedule contract and will be performed in Earth City, Missouri over a four-day period from September 26-29, 2023. As the contract was awarded on a firm...